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In this  case  report  we describe  a case  of the  Kounis–Zavras  syndrome  (coincidental  occurrence  of  chest
pain  and  allergic  reactions  accompanied  by  clinical  and  laboratory  ﬁndings  of  cardiac  ischemia).  A 34-
year-old  woman  presented  to the  emergency  unit  with  severe  chest  pain  from  2  h. She reported  a  medical
history  of asthma.  On  arrival,  her  heart  rate  was  125  beats/min  and  her  systolic  blood pressure  (SBP)  was
70 mmHg.  A  repeated  electrocardiogram  displayed  dynamic  changes  with  ST-segment  elevation  in D1-
aVL leads  and  ST-segment  depression  in  infero-posterior  leads.  Two  episodes  of ventricular  ﬁbrillation
were  observed.  The  coronary  artery  angiography  showed  multivessel  coronary  vasospasms.  Intracoro-
nary  nitroglycerin  was  used  to alleviate  the coronary  vasospasms.  Contemporaneously,  the  patient’s
husband  came  to the  hospital  reporting  a history  of  ketorolac  consumption  some  hours  before  the onset
of the acute  event  for  headache  symptoms.  This  crucial  information  permitted  us  to  suppose  it was  a
case  of  allergic  myocardial  infarction  during  anaphylactic  shock  due  to ketorolac.  Betametasone,  chlor-
phenamine,  and  ranitidine  were  administered  and  progressively  a full recovery  of  SBP  and  of  clinical
status  was  observed.
<Learning  objective:  Allergic  myocardial  infarction  (Kounis-Zavras  syndrome)  is a complex  acute  coro-
nary syndrome  which  requires  rapid  treatment  decisions.  Most  of  the  information  on  this  syndrome
comes  from  case  reports  or small  case  series.  It should  be considered  in young,  healthy  patients  when
they develop  acute  coronary  syndrome  after  administration  of  potentially  allergic  agent.  The  treatment
should both  dilate  coronary  vessels  and suppress  the  allergic  reaction  (steroids,  antihistamines,  ﬂuid
resuscitation,  oxygen,  nitrates,  calcium  channel  blockers).>
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The Kounis–Zavras syndrome, also called allergic angina pec-
oris, is deﬁned as the coincidental occurrence of chest pain and
llergic reactions accompanied by clinical and laboratory ﬁnd-
ngs of classical angina pectoris caused by inﬂammatory mediators
eleased during the allergic insult [1,2]. This syndrome encom-
asses the whole clinical spectrum of acute myocardial ischemia,
rom angina pectoris to acute myocardial infarction (MI), which
ccurs in coincidence with an “allergic” (hypersensitivity, anaphy-
actic, or anaphylactoid) reaction [1,2]. Cardiac symptoms are due
o coronary vasospasm [1,2]. Angina is the more frequent clinical
resentation, whereas MI  is relatively rare. We  report a case of
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allergic MI  that was complicated by malignant ventricular arrhyth-
mias and cardiogenic shock at clinical presentation.
Case report
A 34-year-old woman presented to the emergency unit with
severe chest pain from 2 h. She was accompanied by a friend. She
reported a medical history of asthma (actually in medical treatment
with inhaled corticosteroid, budesonide 800 g die, and -agonist,
formoterol 24 g die). Asthma was  well controlled and in the pre-
vious months no acute exacerbations were reported. She had a 4
month old baby to whom she had given birth without any com-
plications. Five days before the hospital admission, she had been
taking cabergoline (1 mg)  so as to interrupt breast-feeding. Her
pain was  squeezing, substernal, and worsening. On arrival, her
heart rate (HR) was 125 beats/min, and her systolic blood pres-
sure (SBP) was  70 mmHg. She was afebrile. She had bilateral lung
crackles and her chest radiograph revealed a bilateral pulmonary
vier Ltd. All rights reserved.
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ogram during chest pain.
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Fig. 2. Coronary artery angiography showing multivessel vasospasms. (A) RightFig. 1. Electrocardi
dema. Radial and femoral pulses were present, but very weak. A
epeated electrocardiogram displayed dynamic changes with ST-
egment elevation in D1-aVL leads and ST-segment depression
n infero-posterior leads (Fig. 1). These alterations were dynamic
ith signiﬁcant changes related to pain status. An echocardiogram
as immediately performed. The exam showed a left ventricle
ot dilated and hypokinesia of apex. The left ventricle ejection
raction showed a minimal reduction (LVEF = 50%). No pericardial
ffusion was present. The general clinical picture did not indi-
ate pericarditis or myocarditis or peripartum cardiomyopathy. In
ddition, the observed LVEF was not in agreement with a cardio-
enic shock condition. A computed tomography (CT) with contrast
edia was performed to exclude aortic dissection and pulmonary
mbolism. The exam was absolutely negative. 15 min  after the CT,
ardiac arrest due to ventricular ﬁbrillation (VF) was  observed.
inus rhythm recovered with DC shock (150 J). The patient was still
uffering from continued chest pains, her vital parameters were
R 130 beats/min and SBP 65 mmHg. Suspecting spontaneous coro-
ary arteries dissection, an emergency cardiac catheterization was
one.
Unexpectedly, the coronary artery angiography did not dis-
lose any images suggesting a coronary dissection, but instead
or multivessel coronary vasospasms (Fig. 2). During the diag-
ostic exam, a second episode of VF was observed. Interestingly,
rtery spasms were not only limited to coronary arteries. We
bserved also a spasm of femoral artery embracing 6 French
rterial sheath (Fig. 3A). In spite of marked hypotension, intracoro-
ary nitroglycerin was used to alleviate the coronary vasospasms.
ontemporaneously, the patient’s husband came to the hospital
eporting important and crucial anamnestic information. First, the
atient had a history of anaphylactic shock by aspirin (12 years
reviously). Second, some hours before the onset of symptoms and
f the chest pain the patient consumed ketorolac for an important
nd prolonged episode of headache. Both these ﬁndings permit-
ed us to suppose a case of allergic MI  during anaphylactic shock
ue to ketorolac. Betametasone (4 mg), chlorphenamine (10 mg),
nd ranitidine (56 mg)  were administered and progressively a
ecovery of SBP was observed. At coronary artery angiography,
oronary vasospasm was resolved (Fig. 3B). Intravascular ultra-
onography (IVUS) conﬁrmed the absence of coronary dissection
nd of atherosclerotic plaques. During the following days, car-
iac markers conﬁrmed myocardial necrosis (creatine kinase-MB
eak 18.1 ng/dl, normal value <5 ng/dl; troponin I peak 0.16, nor-
al  value <0.015). Electrocardiogram at discharge did not show
 wave. Moreover, a history of nasal polyps emerged conﬁg-
ring the Samter–Beer triad (asthma, aspirin sensitivity, nasal
coronary artery with vasospasm in the ostium and in the proximal portion (red
arrow). (B) Left coronary artery with vasospasm in the left main, in the proximal
and  distal part of left anterior descending, and in the ﬁrst diagonal.
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[ig. 3. Angiography of femoral artery and coronary artery angiography after nitrate
njection. (A) Femoral artery with vasospasm embracing arterial sheath. (B) Reso-
ution of all vasospasms in the left coronary artery after intracoronary injection of
itrates.
olyps). The subsequent hospitalization was uneventful. She had
een treated with verapamil (160 mg  die), ranitidine (300 mg  die),
hlorphenamine (4 mg  die), and inhaled corticosteroids (budes-
nide 1600 g die). At discharge, apex hypokinesia persisted and
VEF = 50%.
iscussion
Kounis–Zavras syndrome is now the term used for allergic
ngina or MI  [1]. Two variants have been described. Type I is
n allergic insult resulting in coronary vasospasm in the set-
ing of normal coronary arteries. The type II variant occurs in a
atient with underlying quiescent coronary atherosclerotic dis-
ase. According the third universal deﬁnition of MI the type I
ariant of Kounis–Zavras syndrome may  be included in the group
f MI  secondary to an ischemic imbalance (type 2) [3]. This sub-
roup included myocardial injury with necrosis, where a condition
ther than coronary artery disease contributes to an imbalance
etween myocardial oxygen supply and/or demand [3].  Also,
[ogy Cases 7 (2013) e74–e77
coronary vasospasm and/or endothelial dysfunction have the
potential to cause type 2 MI  [3].
Our case report is a type I of Kounis–Zavras syndrome which
is peculiar and interesting, principally for its seriousness of
clinical presentation (cardiogenic shock, malignant ventricular
arrhythmias) and for the initial lack of clinical information (aspirin
sensitivity, ketorolac consumption). The trigger of the acute
event (multiple coronary vasospasm with subsequent myocardial
necrosis) was ketorolac, but also the ingestion of cabergoline
(5 days before the acute event) may  be involved in the severity of
clinical presentation. Cabergoline, an ergot derivative, is a potent
dopamine receptor agonist on D2 receptors. Previously, other
authors described similar cases of coronary spasm associated with
MI after the consumption of bromocriptine (an ergot derivative
dopamine receptor agonist like cabergoline) for the suppression of
lactation in the postpartum period [4,5]. The mechanism whereby
these agents could have precipitated coronary artery spasm is not
clear. D2 receptors are associated with inhibition of adenylate
cyclase, and they are located on postganglionic sympathetic
nerve terminals, where they mediate inhibition of norepinephrine
release. In normal conditions, these agents did not have serotonin-
ergic or alpha-adrenergic agonist properties, but it is possible that
in our patient the stimulation of D2-dopaminergic receptors could
have resulted in a paradoxical constrictive response. We  could
speculate that cabergoline may  be responsible for an unusual
pathologic reactivity status of the arterial coronary wall where
ketorolac acted as trigger of multiple coronary vasospasms.
While the exact pathophysiology is not known, inﬂamma-
tory mediators released in the setting of anaphylactic reactions
appear to be the primary mechanism leading to allergic MI. The
mediators released include tryptase, chymase, histamine, platelet-
activating factor, cytokines, and others, as well as prostaglandin
and leukotriene synthesis. Many of these compounds in susceptible
patients induce coronary vasospasm as well as platelet activa-
tion. In these cases, correct and prompt clinical information are
crucial for the diagnosis and for the choice of adequate medi-
cal therapy. To overcome the acute phase, these patients require
corticosteroids, anti-histamines (both H1- and H2-blockers), ﬂuid
resuscitation, and eventually epinephrine, and not the standard
therapy for MI  (e.g. aspirin, heparin, -blockers, angiotensin-
converting enzyme inhibitors, statins, percutaneous coronary
intervention, stent implantation) [6]. Particularly, in these cases
where coronary spasms are linked to allergic tendency, corticoste-
roids are essential (e.g. our patient had bronchial asthma and the
trigger of events has been an allergic reaction to ketorolac) [7,8].
Corticosteroids act principally through two mechanisms: (i) sup-
pressing the hyper-reactivity of the vessel wall by alleviating the
inﬂammation; (ii) direct action on the intracellular Ca2+ signals and
protein kinase C of vascular smooth muscle cells [7,8].
Our case report focused its attention on a very rare clini-
cal entity, largely underdiagnosed, but potentially lethal. Finally,
it is important to be reminded that, in these patients, an
exhaustive allergologic–immunologic evaluation is recommended
so as to identify the triggers and predisposing conditions and
to educate the patient on how to avoid the risk factors for
recurrence.
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